U.S. government will buy more of GlaxoSmithKline and Vir’s COVID antibody drug
November 17, 2021 at 06:13 AM EST
The Glaxo GSK and Vir VIR drug, sotrovimab, was granted emergency authorization by the Food and Drug Administration in May.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|